HomeBUSINESS
BUSINESS

Harvoni Filed for Genotype 2 Hepatitis C: Gilead Japan
(Apr.28.2017)

The Japan arm of Gilead Sciences said on April 28 that it has filed an application seeking an additional indication of genotype 2 hepatitis C for Harvoni (ledipasvir + sofosbuvir), setting the stage for its target population to be expanded to nearly all hepatitis C patients in Japan ...
(LOG IN FOR FULL STORY)

News Calendar